<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th></tr></thead><tbody><tr><td>Mus musculus, <break/>BALB/c</td><td><italic>Il17rb</italic><sup>-/-</sup> (IL-25R<sup>-/-</sup>)</td><td><xref ref-type="bibr" rid="bib40">Neill et al. (2010)</xref> <break/>Nuocytes represent a new innate <break/>effector leukocyte that mediates <break/>type-2 immunity. Nature <break/>464:1367&#8211;1370</td><td/></tr><tr><td>Mus musculus, <break/>C57BL/6</td><td><italic>Rag1</italic><sup>-/-</sup></td><td>Mombaerts,P., Iacomini,J., <break/>Johnson, R.S., Herrup, K., <break/>Tonegawa,S., and Papaioannou, V. E. <break/>1992. Cell. Vol 68: 869&#8211;877. <break/>PMID: 1547488</td><td/></tr><tr><td>Mus musculus, <break/>C57BL/6</td><td><italic>Il4ra</italic>-/-</td><td>Noben-Trauth N, Shultz LD, <break/>Brombacher F, Urban <break/>JF, Jr., Gu H, Paul WE. 1997. <break/>An interleukin 4 (IL-4)-independent <break/>pathway for CD4&#160;+&#160;T cell IL-4 production <break/>is revealed in IL-4 receptor-deficient <break/>mice. Proc Natl Acad Sci <break/>USA 94:10838&#8211;10843.</td><td/></tr><tr><td>Parasite</td><td><italic>Heligmosomoides</italic> <break/> <italic>polygyrus bakeri</italic></td><td><xref ref-type="bibr" rid="bib30">Johnston et al., 2015</xref>. <break/>Cultivation of Heligmosomoides <break/>polygyrus: an immunomodulatory <break/>nematode parasite and its <break/>secreted products. Journal <break/>of Visualized Experiments <break/>98:e52412.</td><td/></tr><tr><td>Antibody</td><td>Anti-IL-4</td><td>BioXCell</td><td>Clone 11B11</td></tr><tr><td>Antibody</td><td>Anti-IL-13</td><td>BioLegend</td><td>JES10-5A2</td></tr><tr><td>Antibody</td><td>Anti-CD90.2</td><td>BioXCell</td><td>30H12</td></tr><tr><td>Antibody</td><td>Anti-SiglecF</td><td>BD Pharmingen</td><td>E50-2440</td></tr><tr><td>Antibody</td><td>Anti-CD11b</td><td>BioLegend</td><td>M1/70</td></tr><tr><td>Antibody</td><td>Anti-F4/80</td><td>BioLegend</td><td>BM8</td></tr><tr><td>Antibody</td><td>Anti-Ly6G</td><td>BioLegend</td><td>1A8</td></tr><tr><td>Antibody</td><td>Anti-Ly6C</td><td>BioLegend</td><td>AL-21</td></tr><tr><td>Antibody</td><td>Anti-RELM&#945;</td><td>R and D Systems</td><td>22603</td></tr><tr><td>Antibody</td><td>Anti-Arginase-1 <break/>(Polyclonal)</td><td>R and D Systems</td><td>IC5868P</td></tr><tr><td>Antibody</td><td>Anti-Lineage</td><td>BioLegend</td><td>17A2,RB6-8C5,RA3-6B2,Ter-119,M1/70</td></tr><tr><td>Peptide, <break/>recombinant protein</td><td>IL-4</td><td>Peprotech</td><td>214&#8211;14</td></tr><tr><td>Peptide, <break/>recombinant protein</td><td>IL-25</td><td>BioLegend</td><td>587302</td></tr><tr><td>Commercial <break/>assay or kit</td><td>Foxp3 Staining Kit</td><td>eBioScience</td><td>88&#8211;8118</td></tr><tr><td>Other</td><td>Control IgG2b <break/>immunoglobulin</td><td>BioXcell</td><td>LTF-2</td></tr><tr><td>Other</td><td>Anti-CD90.2 <break/>Microbeads</td><td>Miltenyi</td><td>130-049-101</td></tr></tbody></table></table-wrap>